Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
30.83
0.00 (0.00%)
Jan 5, 2026, 4:00 PM EST
TKPHF Market Cap
TKPHF has a market cap or net worth of $49.91 billion as of January 7, 2026. Its market cap has increased by 14.50% in one year.
Market Cap
49.91B
Enterprise Value
78.70B
Revenue
29.85B
Ranking
n/a
PE Ratio
223.33
Stock Price
$30.83
Market Cap Chart
Since January 14, 1992, TKPHF's market cap has increased from 8.47B to 49.91B, an increase of 489.18%. That is a compound annual growth rate of 5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 49.52B | 1.33% |
| Dec 30, 2025 | 48.87B | 15.89% |
| Dec 30, 2024 | 42.17B | -6.54% |
| Dec 29, 2023 | 45.12B | -6.90% |
| Dec 30, 2022 | 48.46B | 14.20% |
| Dec 30, 2021 | 42.44B | -25.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 280.10M |